NCT00857506View on ClinicalTrials.gov

Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Alzheimer's DiseaseMild Cognitive Impairment
Interventions
DRUG

florbetapir F 18

370 Mega Becquerel (10 mCi)

Trial Locations (8)

12208

Research Site, Albany

27710

Research Site, Durham

33009

Research Site, Hallandale

33407

Research Site, West Palm Beach

34613

Research Site, Brooksville

85258

Research Site, Scottsdale

85741

Research Site, Tucson

92626

Research Site, Costa Mesa

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY